Skip to main content

Figure S3 from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i>-Mutant Gastric Cancer

Publication ,  Other
Stanland, LJ; Ang, HX; Hoj, JP; Chu, Y; Tan, P; Wood, KC; Luftig, MA
November 1, 2023

<p>Figure S3 shows that Dasatinib renders cells hyper-sensitive to BYL719</p>

Duke Scholars

DOI

Publication Date

November 1, 2023
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stanland, L. J., Ang, H. X., Hoj, J. P., Chu, Y., Tan, P., Wood, K. C., & Luftig, M. A. (2023). Figure S3 from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i>-Mutant Gastric Cancer. https://doi.org/10.1158/1541-7786.24474145.v1
Stanland, Lyla J., Hazel X. Ang, Jacob P. Hoj, Yunqiang Chu, Patrick Tan, Kris C. Wood, and Micah A. Luftig. “Figure S3 from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i>-Mutant Gastric Cancer,” November 1, 2023. https://doi.org/10.1158/1541-7786.24474145.v1.
Stanland, Lyla J., et al. Figure S3 from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i>-Mutant Gastric Cancer. 1 Nov. 2023. Crossref, doi:10.1158/1541-7786.24474145.v1.

DOI

Publication Date

November 1, 2023